Daring discourse - no: cannabinoids should not be used for acute postoperative pain management.
Jennifer D MeekerEugenia AyrianEdward R MarianoPublished in: Regional anesthesia and pain medicine (2020)
As anesthesiologists and acute pain medicine specialists, we will care for patients in the perioperative period who use cannabinoids for chronic pain and/or marijuana recreationally. We will have to address difficult questions from patients regarding the potential applications for cannabinoids in acute pain management. While we must remain compassionate and understand our patients' desire to find relief from suffering using available non-opioid medications, we are ethically bound to do no harm and provide them with treatment options supported by the best available evidence. Today, we cannot support cannabinoids in the management of acute postoperative pain.
Keyphrases
- pain management
- chronic pain
- end stage renal disease
- newly diagnosed
- ejection fraction
- liver failure
- chronic kidney disease
- respiratory failure
- peritoneal dialysis
- prognostic factors
- healthcare
- postoperative pain
- patient reported outcomes
- intensive care unit
- cardiac surgery
- spinal cord injury
- spinal cord
- acute kidney injury
- neuropathic pain
- human health